Aledina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 75,091 | 58,740 | 34,014 | 64,518 | 34,720 | 43,120 | 27,083 | 34,591 |
| Profit before tax | 20,039 | 8,760 | -1,824 | 928 | -5,576 | -6,855 | -5,978 | -1,893 |
| Net profit | 19,950 | 8,760 | -1,824 | 928 | -5,576 | -6,855 | -5,978 | -1,893 |
| Equity | 37,211 | 45,972 | 43,709 | 44,636 | 39,060 | 32,205 | 26,227 | 24,334 |
| Liabilities | 39,892 | 34,627 | 39,611 | 25,086 | 11,839 | 6,221 | 2,671 | 9,636 |
| Non-current assets | 20,770 | 11,794 | 20,615 | 12,376 | 8,755 | 5,135 | 1,514 | 5 |
| Current assets | 56,327 | 46,509 | 45,170 | 44,614 | 30,100 | 22,643 | 19,887 | 26,462 |
| Total assets | 77,097 | 58,303 | 65,785 | 56,990 | 38,855 | 27,778 | 21,401 | 26,467 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,665 | 6,190 | 6,693 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +111.3% | -21.8% | -42.1% | +89.7% | -46.2% | +24.2% | -37.2% | +27.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 25.9% | 15.0% | -2.8% | 1.6% | -14.4% | -24.7% | -27.9% | -7.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 53.6% | 19.1% | -4.2% | 2.1% | -14.3% | -21.3% | -22.8% | -7.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.6% | 14.9% | -5.4% | 1.4% | -16.1% | -15.9% | -22.1% | -5.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 26.7% | 14.9% | -5.4% | 1.4% | -16.1% | -15.9% | -22.1% | -5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.1 | 0.8 | 0.9 | 0.6 | 0.3 | 0.2 | 0.1 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 75,091 | 58,740 | 34,014 | 64,518 | 34,720 | 43,120 | 27,083 | 23,061 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Aledina - Social security debts
The company had no debts to Sodra
Aledina - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Aledina, UAB (code 303225642) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €34.6K and recorded a net loss of €1.9K, corresponding to a negative profit margin of 5.5%. Revenue increased by 27.7% year on year from €27.1K in 2024, although it remained below the €43.1K reported in 2023, meaning the 2-year change was still negative at 19.8%. Losses also narrowed materially from €6.0K in 2024 and €6.9K in 2023, showing a clear improvement in profitability, even though operations remained unprofitable in 2025. At year-end 2025, total assets were €26.5K, equity stood at €24.3K, and liabilities were €9.6K. The equity ratio was 91.9% and debt-to-equity was 0.40, indicating a balance sheet funded mainly by equity. Asset turnover was 1.31x. Revenue per employee was €34.6K, while profit per employee was -€1.9K.